Haemodynamic and clinical effects of ularitide in decompensated heart failure

2006163 citationsJournal Articlebronze Open Access

Authors

V. Mitrovic · Kerckhoff Klinik

Petar Seferović · Institute for Cardiovascular Diseases of Vojvodina

Dejan Simeunović · Institute for Cardiovascular Diseases of Vojvodina

Arsen Ristić · Institute for Cardiovascular Diseases of Vojvodina

Marija Miric · Kliničko Bolnički Centar Zvezdara

V.S. Moiseyev · Peoples' Friendship University of Russia

Zhanna Kobalava

Abstract

Ularitide lowered cardiac filling pressures and improved dyspnoea without apparent early deleterious effects on renal function in DHF patients. These results suggest that ularitide may play a role in the management of DHF.

Topics & Keywords

Heart Failure Treatment and Management Atrial Fibrillation Management and Outcomes Antiplatelet Therapy and Cardiovascular Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 27, Issue 23, pp. 2823-2832

DOI: 10.1093/eurheartj/ehl337

Field-Weighted Citation Impact: 5.66